Poor Awareness of Hypertension in France: The CONSTANCES Population-Based Study.

OBJECTIVES We aimed to assess the hypertension (HTN) awareness and associated factors in France. METHODS We conducted a cross-sectional analysis using data from the CONSTANCES population-based cohort involving 87,808 volunteer participants included between 2012 and 2018. HTN was defined as average blood pressure (BP) over 140/90 or use of BP medication, awareness as self-reported HTN. Multivariable logistic regression models were used to identify the associated factors. RESULTS Overall, 27,160 hypertensive participants (men = 16,569) above 18 years old were analyzed. Hypertension awareness rate was 37.5%. In the multivariable regression model, awareness was predicted by female gender, age, prior cardiovascular disease (CVD), presence of diabetes mellitus (DM), presence of chronic kidney disease (CKD), level of education, and obesity or overweight. Older participants (P < 0.001), females (P < 0.001), participants with comorbidities (P < 0.001), were more likely to be aware when compared with younger participants, males and participants without comorbidities, respectively. The unawareness among participants without cardiometabolic factors (CMF, i.e., CVD, DM, CKD) was higher than participants with CMF (67% vs. 41%, respectively, P < 0.001). Moreover, some differences appeared in both genders in the association between awareness of HTN and health and lifestyle factors. CONCLUSION Our findings show that HTN awareness is low. Particular attention should be given to young men without comorbidities as these characteristics were predictors of poor awareness. Immediate action is required to improve HTN awareness in France.

[1]  V. Gil-Guillén,et al.  Analysing the concept of diagnostic inertia in hypertension: a cross‐sectional study , 2016, International journal of clinical practice.

[2]  J. Blacher.  L’hypertension artérielle en France, une situation préoccupante : une réplique du tremblement de terre cholestérol/statines ? , 2018, La Presse Médicale.

[3]  E. Antman,et al.  Workplace Wellness Recognition for Optimizing Workplace Health: A Presidential Advisory From the American Heart Association , 2015, Circulation.

[4]  B. Everett,et al.  Gender Differences in Hypertension and Hypertension Awareness Among Young Adults , 2015, Biodemography and social biology.

[5]  C. Burt,et al.  Utilization of ambulatory medical care by women: United States, 1997-98. , 2001, Vital and health statistics. Series 13, Data from the National Health Survey.

[6]  Jackson T. Wright,et al.  ORIGINAL INVESTIGATIONS Pathogenesis and Treatment of Kidney Disease Hypertension Awareness, Treatment, and Control in Adults With CKD: Results From the Chronic Renal Insufficiency Cohort (CRIC) Study , 2010 .

[7]  A. Pathak,et al.  Prise en charge de l’hypertension artérielle de l’adulte. Recommandations 2013 de la Société française d’hypertension artérielle ☆ , 2013 .

[8]  Yan Li,et al.  Prevalence, awareness, treatment and control of hypertension in Macau: results from a cross-sectional epidemiological study in Macau, China. , 2015, American journal of hypertension.

[9]  Julie Gourmelen,et al.  The CONSTANCES cohort: an open epidemiological laboratory , 2010, BMC public health.

[10]  Silke L. Schneider.  The International Standard Classification of Education 2011 , 2013 .

[11]  D. Arveiler,et al.  Sex differences in awareness and control of hypertension in France , 1997, Journal of hypertension.

[12]  N. Hoertel,et al.  Job exposure to the public in relation with alcohol, tobacco and cannabis use: Findings from the CONSTANCES cohort study , 2018, PloS one.

[13]  K. Reynolds,et al.  Global burden of hypertension: analysis of worldwide data , 2005, The Lancet.

[14]  Société française d’hypertension artérielle.  [Guidelines of the French Society of Hypertension: blood pressure measurements in the diagnosis and monitoring of hypertensive patients]. , 2012, Presse medicale.

[15]  M. Tremblay,et al.  Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades , 2011, Canadian Medical Association Journal.

[16]  Asher Mullard.  Mediator scandal engulfs French compensation body , 2013, The Lancet.

[17]  P. Whelton,et al.  Trends in the prevalence, awareness, treatment, and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke. , 2006, American journal of epidemiology.

[18]  K. Stronks,et al.  Factors associated with hypertension awareness, treatment and control among ethnic groups in Amsterdam, The Netherlands: The SUNSET study , 2006, Journal of Human Hypertension.

[19]  [Management of adults with essential hypertension--2005 update--guidelines]. , 2006, Journal des maladies vasculaires.

[20]  V. Aboyans,et al.  DÉPISTAGE DE L'ARTÉRIOPATHIE INFRA-CLINIQUE DES MEMBRES INFÉRIEURS. , 2006 .

[21]  F. Hu,et al.  Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. , 2007, Archives of internal medicine.

[22]  Gilles Chatellier,et al.  Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. , 2004, JAMA.

[23]  D. Arveiler,et al.  High blood pressure prevalence and control in a middle-aged French population and their associated factors: the MONA LISA study , 2011, Journal of hypertension.

[24]  W. Courtenay.  Constructions of masculinity and their influence on men's well-being: a theory of gender and health. , 2000, Social science & medicine.

[25]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[26]  N. Roche,et al.  High quality standards for a large-scale prospective population-based observational cohort: Constances , 2016, BMC Public Health.

[27]  Gretchen A. Stevens,et al.  Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys , 2019, The Lancet.

[28]  J. Ménard,et al.  Le nécessaire tournant organisationnel de la France dans les maladies hypertensives , 2018, La Presse Médicale.

[29]  G. Parati,et al.  Home or ambulatory blood pressure monitoring for the diagnosis of hypertension? , 2015, Journal of hypertension.

[30]  Martin McKee,et al.  Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. , 2013, JAMA.

[31]  H. Neuhauser,et al.  Hypertension prevalence, awareness, treatment and control in Germany 1998 and 2008–11 , 2014, Journal of Human Hypertension.

[32]  Ori Rogowski,et al.  Blood pressure level and hypertension awareness and control differ by marital status, sex, and ethnicity: a population-based study. , 2014, American journal of hypertension.

[33]  M. Zins,et al.  The French CONSTANCES population-based cohort: design, inclusion and follow-up , 2015, European Journal of Epidemiology.

[34]  H. Lei,et al.  Hypertension prevalence, awareness, treatment, control, and associated factors in Southwest China: an update , 2017, Journal of hypertension.

[35]  G. Chatellier,et al.  Prevalence and Therapeutic Control of Hypertension in 30 000 Subjects in the Workplace , 2001, Hypertension.

[36]  M. Zins,et al.  Unhealthy behaviours and risk of visual impairment: The CONSTANCES population-based cohort , 2018, Scientific Reports.

[37]  F. Zannad,et al.  Influence of the recommendations on the implementation of home blood pressure measurement by French general practitioners: a 2004–2009 longitudinal survey , 2011, Journal of hypertension.